No connection

Search Results

BH

BEARISH
$467.14 Live
Biglari Holdings Inc. · NYSE
$195.05 52W Range $483.6

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$1.46B
P/E
217.27
ROE
0.4%
Profit margin
0.5%
Debt/Equity
0.6
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
78%
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong recent price performance (+110.4% over 1Y), the stock trades at an extremely high P/E of 217.27 versus negative Forward P/E, signaling earnings deterioration. Profitability metrics are concerning, with a mere 0.54% net margin and 0.35% ROE, well below sector averages. While the balance sheet shows a healthy current ratio and low Price/Book of 0.50, these are overshadowed by unsustainable valuation and weak earnings momentum.

Key Strengths

Strong liquidity position with Current Ratio of 2.83 and Quick Ratio of 2.73, indicating solid short-term financial health
Low Price/Book ratio of 0.50 suggests potential undervaluation on a book value basis
Revenue growth of 10.30% YoY outpaces sector average of 7.54%, showing top-line resilience
High insider sentiment score of 60/100, indicating management confidence despite no recent trading activity
Significant 5-year price appreciation of +310.2%, reflecting strong investor interest and market momentum

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health, particularly in profitability and leverage trends
Extremely high P/E ratio of 217.27 and negative Forward P/E suggest severe earnings deterioration and overvaluation
Negative earnings growth (Q/Q EPS change: -695.7%) raises concerns about profitability sustainability
Absence of Altman Z-Score due to missing data increases uncertainty around bankruptcy risk
No analyst coverage and missing key financials (EV, debt, cash, shares) limit transparency and increase investment risk
AI Fair Value Estimate
Based on comprehensive analysis
$212.68
-54.5% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
34
Weak
Value
30
Future
35
Past
65
Health
40
Dividend
0
AI Verdict
Caution advised due to weak profitability, high valuation, and lack of analyst coverage
Key drivers: High P/E and negative forward earnings, Low Piotroski F-Score, Missing Altman Z-Score and key financials, Strong revenue growth and liquidity, Significant price run-up without earnings support
Confidence
75%
Value
30/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Book of 0.50 is below 1.0, suggesting possible asset-based undervaluation
  • Graham Number of $212.68 provides a conservative value floor
Watchpoints
  • P/E of 217.27 is extremely high and unjustifiable relative to earnings
  • Forward P/E of -62.70 indicates expected losses
  • PEG Ratio unavailable due to non-positive earnings
Future
35/100

Ref Growth rates

Positives
  • 10.30% YoY revenue growth above sector average
  • Historical earnings surprises have been positive on average (28.00%)
Watchpoints
  • Most recent Q/Q EPS growth is -695.7%, signaling sharp earnings decline
  • Forward P/E negative, implying no near-term profitability recovery
Past
65/100

Ref Historical trends

Positives
  • 5-year price return of +310.2% demonstrates strong historical performance
  • Earnings beat rate of 50% over last 4 quarters (2/4)
Watchpoints
  • Earnings progression shows deepening losses (e.g., $-3.74 in latest reported quarter)
  • Long gaps in earnings data and outdated reporting dates (e.g., 2019, 2018)
Health
40/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Debt/Equity of 0.60 is below sector average of 1.71, indicating conservative leverage
  • Current and Quick Ratios above 2.7 suggest strong liquidity
Watchpoints
  • Piotroski F-Score of 4/9 indicates weak financial health
  • No Altman Z-Score due to missing inputs, increasing risk uncertainty
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend Strength of 0/100 and no dividend yield
  • Payout ratio is 0.00%, indicating no return to shareholders

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$467.14

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BH and closest competitors.

Updated 2026-01-23
BH
Biglari Holdings Inc.
Primary
5Y
+310.2%
3Y
+205.9%
1Y
+110.4%
6M
+46.2%
1M
+29.3%
1W
+1.5%
TRS
TriMas Corporation
Peer
5Y
+27.2%
3Y
+44.6%
1Y
+90.0%
6M
+1.4%
1M
+12.4%
1W
-1.5%
REA
The RealReal, Inc.
Peer
5Y
-47.8%
3Y
+923.7%
1Y
+124.5%
6M
+17.7%
1M
+28.0%
1W
+24.7%
WIN
Winmark Corporation
Peer
5Y
+143.2%
3Y
+25.4%
1Y
+15.2%
6M
-3.9%
1M
-5.2%
1W
+4.9%
BH-
Biglari Holdings Inc.
Peer
5Y
+361.4%
3Y
+231.2%
1Y
+131.1%
6M
+55.9%
1M
+29.8%
1W
+2.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
217.27
Forward P/E
-62.7
PEG Ratio
N/A
P/B Ratio
0.5
P/S Ratio
3.78
EV/Revenue
0.69
EV/EBITDA
4.18
Market Cap
$1.46B

Profitability

Profit margins and return metrics

Profit Margin 0.54%
Operating Margin 9.12%
Gross Margin 38.28%
ROE 0.35%
ROA 1.54%

Growth

Revenue and earnings growth rates

Revenue Growth +10.3%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.6
Moderate
Current Ratio
2.83
Strong
Quick Ratio
2.73
Excellent
Cash/Share
$594.87

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-28
$N/A
2019-02-25
$-3.74
-25.5% surprise
2018-11-02
$-0.47
+13.1% surprise
2018-08-03
$-0.05
+96.4% surprise

Consumer Cyclical Sector Comparison

Comparing BH against 386 companies in the Consumer Cyclical sector (23 bullish, 133 neutral, 230 bearish)
P/E Ratio
217.27
This Stock
vs
33.98
Sector Avg
+539.4% (Expensive)
Return on Equity (ROE)
0.35%
This Stock
vs
-43.92%
Sector Avg
-100.8% (Below Avg)
Profit Margin
0.54%
This Stock
vs
-5.4%
Sector Avg
-110.0% (Weaker)
Debt to Equity
0.6
This Stock
vs
1.51
Sector Avg
-60.5% (Less Debt)
Revenue Growth
10.3%
This Stock
vs
28.42%
Sector Avg
-63.8% (Slower)
Current Ratio
2.83
This Stock
vs
2.46
Sector Avg
+15.1% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

BIGLARI SARDAR
Chief Executive Officer
Buy
2025-12-17
3,084 shares · $998,322
BIGLARI SARDAR
Chief Executive Officer
Buy
2025-12-15
601 shares · $199,436
BIGLARI SARDAR
Chief Executive Officer
Buy
2025-12-10
2,221 shares · $705,671
BIGLARI SARDAR
Chief Executive Officer
Buy
2025-12-05
5,406 shares · $1,648,102
BIGLARI SARDAR
Chief Executive Officer
Buy
2025-11-24
1,819 shares · $499,752
Insider transactions can signal confidence or concerns about company prospects

Past News Coverage

Recent headlines mentioning BH from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile